Literature DB >> 24323452

Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation.

Yi Yang1, Carol Inatsuka1, Ekram Gad1, Mary L Disis1, Leanna J Standish2, Nirmal Pugh3, David S Pasco3, Hailing Lu4.   

Abstract

Inflammasome activation has been shown to regulate both innate and adaptive immune responses. It is important to investigate whether immune-enhancing natural products can also activate inflammasome. The current study examined the potential of protein-bound polysaccharide-K (PSK), a hot water extract from Trametes versicolor, to activate inflammasome. Using THP-1 cells, we have demonstrated that PSK induces both pro-IL-1β and mature IL-1β in THP-1 cells in a caspase 1- and NLRP3-dependent manner. PSK also induces IL-1β and IL-18 in human PBMC. Cathepsin B is required for PSK-induced inflammasome activation as CA-074-Me, a cathepsin B inhibitor, significantly decreased PSK-induced IL-1β. PSK induces NLRP3 at both mRNA and protein level. Comparison of PSK-induced IL-1β in bone marrow-derived macrophages from wild type C57BL/6 mice, TLR2(-/-), P2X7R(-/-) and NLRP3(-/-) mice demonstrated that PSK-induced IL-1β is dependent on both TLR2 and NLRP3. P2X7R is not required for PSK-induced inflammasome activation, but enhances PSK-induced caspase-1 activation and IL-1β induction. Altogether, these results demonstrated that PSK induces inflammasome activation and production of IL-1β in a TLR2- and NLRP3-dependent mechanism. These results provide novel insights into the mechanisms of the immune modulatory effects of PSK.
© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  NLRP3 inflammasome; PSK; TLR2

Mesh:

Substances:

Year:  2013        PMID: 24323452      PMCID: PMC4414124          DOI: 10.1177/1753425913513814

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  38 in total

Review 1.  Sensing and reacting to microbes through the inflammasomes.

Authors:  Luigi Franchi; Raul Muñoz-Planillo; Gabriel Núñez
Journal:  Nat Immunol       Date:  2012-03-19       Impact factor: 25.606

2.  Bone Marrow-Derived Macrophages (BMM): Isolation and Applications.

Authors:  Joachim Weischenfeldt; Bo Porse
Journal:  CSH Protoc       Date:  2008-12-01

3.  TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo.

Authors:  Yuan He; Luigi Franchi; Gabriel Núñez
Journal:  J Immunol       Date:  2012-12-07       Impact factor: 5.422

Review 4.  Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.

Authors:  Laetitia Aymeric; Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Isabelle Martins; Guido Kroemer; Mark J Smyth; Laurence Zitvogel
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

5.  Immunochemotherapy in B-16-melanoma-cell-transplanted mice with combinations of interleukin-2, cyclophosphamide, and PSK.

Authors:  Y Ueno; Y Kohgo; S Sakamaki; Y Itoh; M Takahashi; Y Hirayama; Y Niitsu
Journal:  Oncology       Date:  1994 May-Jun       Impact factor: 2.935

6.  Antitumor effect of biological response modifier, PSK, on C57BL/6 mice with syngeneic melanoma B16 and its mode of action.

Authors:  K Matsunaga; M Aota; Y Nyunoya; M Hakozaki; Y Ishikawa; M Ohhara; N Sugita; H Endo
Journal:  Oncology       Date:  1994 Jul-Aug       Impact factor: 2.935

7.  Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth.

Authors:  Mélanie Bruchard; Grégoire Mignot; Valentin Derangère; Fanny Chalmin; Angélique Chevriaux; Frédérique Végran; Wilfrid Boireau; Benoit Simon; Bernhard Ryffel; Jean Louis Connat; Jean Kanellopoulos; François Martin; Cédric Rébé; Lionel Apetoh; François Ghiringhelli
Journal:  Nat Med       Date:  2012-12-02       Impact factor: 53.440

Review 8.  The P2X7 receptor: a key player in IL-1 processing and release.

Authors:  Davide Ferrari; Cinzia Pizzirani; Elena Adinolfi; Roberto M Lemoli; Antonio Curti; Marco Idzko; Elisabeth Panther; Francesco Di Virgilio
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

9.  Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion.

Authors:  Saïdi M'Homa Soudja; Anne L Ruiz; Julien C Marie; Grégoire Lauvau
Journal:  Immunity       Date:  2012-08-30       Impact factor: 31.745

10.  Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants.

Authors:  Stephanie C Eisenbarth; Oscar R Colegio; William O'Connor; Fayyaz S Sutterwala; Richard A Flavell
Journal:  Nature       Date:  2008-05-21       Impact factor: 49.962

View more
  4 in total

1.  Combining immunotherapy and natural immune stimulants: mechanisms and clinical implications.

Authors:  Khara Lucius; Jacob Hill
Journal:  J Cancer Res Clin Oncol       Date:  2019-01-23       Impact factor: 4.553

2.  Ugonin U stimulates NLRP3 inflammasome activation and enhances inflammasome-mediated pathogen clearance.

Authors:  Chun-Yu Chen; Chuan-Hui Yang; Yung-Fong Tsai; Chih-Chuang Liaw; Wen-Yi Chang; Tsong-Long Hwang
Journal:  Redox Biol       Date:  2016-12-18       Impact factor: 11.799

Review 3.  Ketogenic and Modified Mediterranean Diet as a Tool to Counteract Neuroinflammation in Multiple Sclerosis: Nutritional Suggestions.

Authors:  Danila Di Majo; Francesco Cacciabaudo; Giulia Accardi; Giuditta Gambino; Giuseppe Giglia; Giuseppe Ferraro; Giuseppina Candore; Pierangelo Sardo
Journal:  Nutrients       Date:  2022-06-08       Impact factor: 6.706

Review 4.  Integrative considerations during the COVID-19 pandemic.

Authors:  Lise Alschuler; Andrew Weil; Randy Horwitz; Paul Stamets; Ann Marie Chiasson; Robert Crocker; Victoria Maizes
Journal:  Explore (NY)       Date:  2020-03-26       Impact factor: 1.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.